BEGIN:VCALENDAR VERSION:2.0 PRODID:-//wp-events-plugin.com//7.2.3.1//EN TZID:America/New_York X-WR-TIMEZONE:America/New_York BEGIN:VEVENT UID:676@vydya.com DTSTART;TZID=Europe/Paris:20250922T090000 DTEND;TZID=Europe/Paris:20250923T180000 DTSTAMP:20241015T175930Z URL:https://www.vydya.com/events/biomarkers-conference-2025-paris/ SUMMARY:21st Global Biomarkers and Clinical Research Summit DESCRIPTION:The 21st Global Biomarkers and Clinical Research Summit\, sched uled for September 22-23\, 2025\, in Paris\, France\, will bring together leading scientists\, clinicians\, and industry experts to discuss the late st advancements in biomarker research and their pivotal role in clinical p ractice. Biomarkers are transforming the landscape of personalized medicin e\, offering new avenues for early detection\, diagnosis\, and treatment o f diseases. This summit will focus on the integration of biomarkers into c linical trials\, drug development\, and precision medicine\, alongside eme rging technologies such as AI-driven diagnostics and next-generation seque ncing.\n\nTHEME: Collaborative Innovations: Building Networks in Biomarker and Clinical Research\n\nThe event will feature a diverse range of topics including biomarker discovery\, validation\, regulatory challenges\, and their clinical applications in various therapeutic areas such as oncology\ , cardiology\, neurology\, and rare diseases. Participants will have the o pportunity to engage in keynote lectures\, panel discussions\, and hands-o n workshops\, fostering a collaborative environment for knowledge exchange and innovation. With contributions from academia\, industry\, and regulat ory bodies\, the summit aims to bridge the gap between research and clinic al implementation\, paving the way for future breakthroughs in healthcare. \nConference Scientific Sessions\nNovel Biomarker Discovery Techniques\nOm ics Approaches in Biomarker Identification\nBiomarkers in Precision Medici ne\nClinical Applications of Biomarkers in Oncology\nBiomarkers in Cardiov ascular Diseases\nMicrobiome as a Biomarker: Implications for Health\nPhar macogenomics and Biomarkers in Drug Development\nBiomarkers in Autoimmune Disorders\nIntegrating AI and Machine Learning in Biomarker Research\nRegu latory Considerations for Biomarker Validation\nBiomarkers in Infectious D iseases\nLiquid Biopsies: Techniques and Applications\nBiomarkers in Neuro logical Disorders\nPersonalized Treatment Strategies Based on Biomarker Pr ofiles\nBiomarkers for Early Detection of Chronic Diseases\nBiomarkers in Rare Diseases: Challenges and Opportunities\nEthical Considerations in Bio marker Research\nBiomarker Development in Clinical Trials\nBiomarkers in W omen’s Health\nBiomarkers and Patient-Centric Research\nNext-Generation Sequencing in Biomarker Discovery\nValidation of Biomarkers in Real-World Settings\nBiomarkers for Response Prediction in Immunotherapy\nBiomarkers in Pediatric Medicine\nBioinformatics Approaches in Biomarker Analysis\nRo le of Proteomics in Biomarker Discovery\nBiomarkers and Patient Stratifica tion in Clinical Practice\nIntegration of Biomarkers in Health Economics a nd Outcomes Research\nCollaborative Models in Biomarker Research\nFuture D irections in Biomarker Research and Development\n\n \; ATTACH;FMTTYPE=image/jpeg:https://www.vydya.com/wp-content/uploads/2024/10 /Biomarkers-Ban-1.jpg CATEGORIES:CME Conference,CPD Conference,Medical Conference,Pharmacy Conference,Research & Development END:VEVENT BEGIN:VTIMEZONE TZID:Europe/Paris X-LIC-LOCATION:Europe/Paris BEGIN:DAYLIGHT DTSTART:20250330T030000 TZOFFSETFROM:+0100 TZOFFSETTO:+0200 TZNAME:CEST END:DAYLIGHT END:VTIMEZONE END:VCALENDAR